Cerenome (CNSY) FCF Margin (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) FCF Margin (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 70.82% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -22.35% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -1,856.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,856.69% |
| Mar 31, 2026 | -686.38% |
| Dec 31, 2025 | -461.74% |
| Sep 30, 2025 | -184.32% |
| Jun 30, 2025 | -417.63% |
| Mar 31, 2025 | -583.10% |
| Dec 31, 2024 | -86.54% |
| Sep 30, 2024 | -253.71% |
| Jun 30, 2024 | -96.25% |
| Mar 31, 2024 | -271.50% |
| Dec 31, 2023 | 48.29% |
| Sep 30, 2023 | -54.75% |
| Jun 30, 2023 | -146.79% |
| Mar 31, 2023 | -1,164.03% |
| Dec 31, 2022 | -3,473.51% |
| Sep 30, 2022 | -4,427.40% |
| Mar 31, 2019 | -466.00% |
| Dec 31, 2018 | -175.32% |
| Sep 30, 2018 | -314.34% |
| Jun 30, 2018 | -416.06% |